[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.699, "open": 0.69, "dayLow": 0.6798, "dayHigh": 0.7198, "regularMarketPreviousClose": 0.699, "regularMarketOpen": 0.69, "regularMarketDayLow": 0.6798, "regularMarketDayHigh": 0.7198, "payoutRatio": 0.0, "beta": 1.894, "forwardPE": -2.482069, "volume": 115951, "regularMarketVolume": 115951, "averageVolume": 236739, "averageVolume10days": 123240, "averageDailyVolume10Day": 123240, "bid": 0.4935, "ask": 0.8853, "bidSize": 2, "askSize": 2, "marketCap": 64569084, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.68654, "twoHundredDayAverage": 1.01443, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -18780650, "profitMargins": 0.0, "floatShares": 39385523, "sharesOutstanding": 89704200, "sharesShort": 1598626, "sharesShortPriorMonth": 1724171, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0178, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.79933, "shortRatio": 9.43, "shortPercentOfFloat": 0.0216, "impliedSharesOutstanding": 89704200, "bookValue": 0.92, "priceToBook": 0.7823913, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -34207572, "trailingEps": -0.28, "forwardEps": -0.29, "enterpriseToEbitda": 0.491, "52WeekChange": -0.7075314, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 0.7198, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.2, "targetMedianPrice": 4.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 83517048, "totalCashPerShare": 0.931, "ebitda": -38285488, "totalDebt": 167319, "quickRatio": 18.333, "currentRatio": 19.087, "debtToEquity": 0.203, "returnOnAssets": -0.25215, "returnOnEquity": -0.37252998, "freeCashflow": -37020280, "operatingCashflow": -17703620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754692295, "regularMarketTime": 1754683201, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.97568, "regularMarketPrice": 0.7198, "firstTradeDateMilliseconds": 1634736600000, "cryptoTradeable": false, "hasPrePostMarketData": true, "postMarketChangePercent": 0.0277901, "postMarketPrice": 0.72, "postMarketChange": 0.000200033, "regularMarketChange": 0.0208, "regularMarketDayRange": "0.6798 - 0.7198", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 236739, "fiftyTwoWeekLowChange": 0.22979999, "fiftyTwoWeekLowChangePercent": 0.46897957, "fiftyTwoWeekRange": "0.49 - 2.75", "fiftyTwoWeekHighChange": -2.0302, "fiftyTwoWeekHighChangePercent": -0.73825455, "fiftyTwoWeekChangePercent": -70.753136, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.29, "epsCurrentYear": -0.268, "priceEpsCurrentYear": -2.6858208, "fiftyDayAverageChange": 0.033259988, "fiftyDayAverageChangePercent": 0.048445813, "twoHundredDayAverageChange": -0.29463005, "twoHundredDayAverageChangePercent": -0.290439, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.7 - Buy", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]